Jens Kuhn
Concepts (856)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Viruses | 50 | 2026 | 165 | 15.320 |
Why?
| | Genome, Viral | 83 | 2026 | 217 | 14.260 |
Why?
| | RNA Viruses | 33 | 2025 | 75 | 12.930 |
Why?
| | Ebolavirus | 55 | 2026 | 91 | 10.360 |
Why?
| | Hemorrhagic Fever, Ebola | 44 | 2026 | 82 | 8.090 |
Why?
| | Phylogeny | 88 | 2026 | 924 | 8.050 |
Why?
| | Filoviridae | 22 | 2023 | 27 | 6.740 |
Why?
| | Terminology as Topic | 32 | 2026 | 253 | 6.150 |
Why?
| | Mononegavirales | 10 | 2022 | 10 | 5.030 |
Why?
| | Deep Brain Stimulation | 26 | 2026 | 223 | 4.790 |
Why?
| | Classification | 22 | 2026 | 44 | 4.460 |
Why?
| | Virus Replication | 42 | 2026 | 526 | 3.970 |
Why?
| | Arterivirus | 15 | 2024 | 18 | 3.620 |
Why?
| | Tourette Syndrome | 12 | 2025 | 28 | 3.560 |
Why?
| | RNA, Viral | 32 | 2024 | 693 | 3.310 |
Why?
| | Marburgvirus | 11 | 2024 | 21 | 2.940 |
Why?
| | Virion | 23 | 2026 | 112 | 2.830 |
Why?
| | Arenaviridae | 10 | 2024 | 12 | 2.740 |
Why?
| | Viral Proteins | 22 | 2026 | 351 | 2.560 |
Why?
| | Antiviral Agents | 17 | 2024 | 779 | 2.530 |
Why?
| | Arthropods | 4 | 2024 | 12 | 2.490 |
Why?
| | Animals | 169 | 2026 | 38106 | 2.350 |
Why?
| | Open Reading Frames | 10 | 2024 | 130 | 2.260 |
Why?
| | Obsessive-Compulsive Disorder | 9 | 2026 | 60 | 2.210 |
Why?
| | Hemorrhagic Fevers, Viral | 9 | 2022 | 16 | 2.200 |
Why?
| | Virus Internalization | 18 | 2022 | 65 | 2.100 |
Why?
| | Arterivirus Infections | 9 | 2019 | 10 | 2.090 |
Why?
| | Virology | 12 | 2025 | 37 | 2.050 |
Why?
| | Nucleoproteins | 10 | 2024 | 37 | 2.010 |
Why?
| | Host-Pathogen Interactions | 17 | 2026 | 366 | 1.950 |
Why?
| | Flaviviridae | 4 | 2025 | 10 | 1.940 |
Why?
| | Ebola Vaccines | 9 | 2026 | 13 | 1.900 |
Why?
| | Arenaviridae Infections | 9 | 2024 | 18 | 1.880 |
Why?
| | DNA Viruses | 10 | 2026 | 24 | 1.800 |
Why?
| | Filoviridae Infections | 5 | 2019 | 8 | 1.770 |
Why?
| | Rhabdoviridae | 4 | 2024 | 4 | 1.740 |
Why?
| | Viroids | 3 | 2024 | 6 | 1.690 |
Why?
| | Hemorrhagic Fever Virus, Crimean-Congo | 8 | 2025 | 13 | 1.660 |
Why?
| | Receptors, Virus | 11 | 2015 | 91 | 1.660 |
Why?
| | Antibodies, Viral | 18 | 2026 | 689 | 1.620 |
Why?
| | Bunyaviridae | 4 | 2024 | 4 | 1.570 |
Why?
| | Hemorrhagic Fever, Crimean | 7 | 2025 | 11 | 1.570 |
Why?
| | Viral Vaccines | 9 | 2020 | 107 | 1.520 |
Why?
| | Monkey Diseases | 5 | 2020 | 25 | 1.480 |
Why?
| | Evolution, Molecular | 14 | 2026 | 502 | 1.330 |
Why?
| | Humans | 205 | 2026 | 146342 | 1.320 |
Why?
| | Containment of Biohazards | 9 | 2026 | 23 | 1.310 |
Why?
| | Wasps | 6 | 2024 | 23 | 1.300 |
Why?
| | Connectome | 4 | 2026 | 100 | 1.220 |
Why?
| | Disease Outbreaks | 20 | 2021 | 422 | 1.170 |
Why?
| | Chiroptera | 7 | 2021 | 59 | 1.140 |
Why?
| | Communicable Diseases, Emerging | 5 | 2025 | 39 | 1.140 |
Why?
| | Brain | 17 | 2026 | 2991 | 1.130 |
Why?
| | Green Fluorescent Proteins | 3 | 2023 | 408 | 1.130 |
Why?
| | Nipah Virus | 3 | 2025 | 3 | 1.090 |
Why?
| | Lassa virus | 7 | 2023 | 12 | 1.070 |
Why?
| | Henipavirus Infections | 2 | 2025 | 2 | 1.070 |
Why?
| | Genetic Variation | 13 | 2020 | 996 | 1.070 |
Why?
| | Glycoproteins | 14 | 2026 | 356 | 1.070 |
Why?
| | Vero Cells | 18 | 2023 | 84 | 1.060 |
Why?
| | Viral Envelope Proteins | 12 | 2025 | 97 | 1.020 |
Why?
| | Basal Nucleus of Meynert | 3 | 2017 | 4 | 1.000 |
Why?
| | Organoids | 2 | 2026 | 143 | 0.990 |
Why?
| | Delay Discounting | 3 | 2023 | 29 | 0.990 |
Why?
| | Drug Evaluation, Preclinical | 5 | 2020 | 195 | 0.970 |
Why?
| | Macaca mulatta | 12 | 2025 | 188 | 0.960 |
Why?
| | RNA Virus Infections | 5 | 2018 | 20 | 0.960 |
Why?
| | Monkeypox virus | 4 | 2025 | 23 | 0.940 |
Why?
| | Animal Use Alternatives | 1 | 2025 | 1 | 0.920 |
Why?
| | Biomedical Research | 6 | 2026 | 729 | 0.880 |
Why?
| | Coronavirus Infections | 8 | 2020 | 379 | 0.880 |
Why?
| | Pyrimidine Nucleosides | 2 | 2022 | 3 | 0.880 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2025 | 60 | 0.870 |
Why?
| | Nairovirus | 3 | 2024 | 3 | 0.850 |
Why?
| | Primates | 12 | 2023 | 133 | 0.840 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2025 | 78 | 0.840 |
Why?
| | Archaeal Viruses | 4 | 2025 | 12 | 0.830 |
Why?
| | Genomics | 13 | 2024 | 853 | 0.820 |
Why?
| | Helper Viruses | 1 | 2024 | 3 | 0.820 |
Why?
| | Cell Line | 22 | 2026 | 2814 | 0.810 |
Why?
| | DNA, Complementary | 4 | 2021 | 269 | 0.810 |
Why?
| | Recombination, Genetic | 2 | 2024 | 202 | 0.810 |
Why?
| | Viral Core Proteins | 2 | 2020 | 21 | 0.800 |
Why?
| | Primate Diseases | 4 | 2018 | 8 | 0.790 |
Why?
| | Antibodies, Monoclonal | 7 | 2025 | 1512 | 0.790 |
Why?
| | Flavivirus | 1 | 2023 | 19 | 0.770 |
Why?
| | Thalamus | 6 | 2025 | 134 | 0.770 |
Why?
| | Antigens, CD | 7 | 2023 | 560 | 0.770 |
Why?
| | Polydnaviridae | 1 | 2023 | 1 | 0.770 |
Why?
| | Rhabdoviridae Infections | 2 | 2020 | 2 | 0.750 |
Why?
| | Mammals | 6 | 2024 | 288 | 0.750 |
Why?
| | Arteriviridae | 4 | 2018 | 4 | 0.750 |
Why?
| | Databases, Nucleic Acid | 3 | 2023 | 39 | 0.740 |
Why?
| | Disease Reservoirs | 4 | 2017 | 28 | 0.730 |
Why?
| | Nucleus Accumbens | 10 | 2026 | 135 | 0.730 |
Why?
| | Arenaviruses, New World | 6 | 2013 | 9 | 0.730 |
Why?
| | Antibodies, Neutralizing | 9 | 2025 | 348 | 0.700 |
Why?
| | Frontal Lobe | 3 | 2025 | 159 | 0.690 |
Why?
| | Alzheimer Disease | 3 | 2017 | 641 | 0.680 |
Why?
| | Clinical Deterioration | 1 | 2021 | 10 | 0.660 |
Why?
| | Virus Diseases | 3 | 2020 | 219 | 0.660 |
Why?
| | Macaca | 6 | 2025 | 66 | 0.660 |
Why?
| | Pan troglodytes | 2 | 2021 | 62 | 0.660 |
Why?
| | Lassa Fever | 4 | 2023 | 7 | 0.660 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 3 | 2016 | 11 | 0.660 |
Why?
| | Post-Exposure Prophylaxis | 2 | 2020 | 13 | 0.650 |
Why?
| | Marburg Virus Disease | 4 | 2023 | 11 | 0.650 |
Why?
| | Picornaviridae | 1 | 2020 | 18 | 0.650 |
Why?
| | Parkinson Disease | 4 | 2022 | 614 | 0.650 |
Why?
| | Impulsive Behavior | 2 | 2022 | 146 | 0.640 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 3 | 2023 | 66 | 0.640 |
Why?
| | Neutralization Tests | 3 | 2019 | 74 | 0.630 |
Why?
| | Symbiosis | 2 | 2024 | 71 | 0.630 |
Why?
| | Biological Evolution | 7 | 2024 | 471 | 0.630 |
Why?
| | Picornaviridae Infections | 1 | 2020 | 53 | 0.620 |
Why?
| | International Cooperation | 3 | 2021 | 193 | 0.620 |
Why?
| | Biodiversity | 2 | 2022 | 314 | 0.620 |
Why?
| | Receptors, Transferrin | 4 | 2013 | 28 | 0.610 |
Why?
| | World Health Organization | 2 | 2021 | 104 | 0.610 |
Why?
| | Bornaviridae | 2 | 2021 | 2 | 0.610 |
Why?
| | Metagenomics | 8 | 2024 | 154 | 0.600 |
Why?
| | Membrane Glycoproteins | 7 | 2015 | 495 | 0.590 |
Why?
| | Staining and Labeling | 2 | 2020 | 148 | 0.580 |
Why?
| | Antipsychotic Agents | 1 | 2021 | 185 | 0.580 |
Why?
| | Luminescent Agents | 1 | 2018 | 7 | 0.570 |
Why?
| | Receptors, Cell Surface | 4 | 2023 | 371 | 0.560 |
Why?
| | Internal Capsule | 6 | 2026 | 10 | 0.560 |
Why?
| | Sequence Analysis, DNA | 13 | 2017 | 771 | 0.560 |
Why?
| | Corpus Striatum | 1 | 2020 | 181 | 0.550 |
Why?
| | Genes, Reporter | 2 | 2018 | 275 | 0.550 |
Why?
| | Reverse Transcription | 1 | 2018 | 20 | 0.550 |
Why?
| | Macaca fascicularis | 3 | 2021 | 70 | 0.540 |
Why?
| | Archaea | 3 | 2025 | 62 | 0.540 |
Why?
| | Hantavirus Pulmonary Syndrome | 3 | 2023 | 5 | 0.540 |
Why?
| | Amino Acid Sequence | 16 | 2020 | 2092 | 0.530 |
Why?
| | Influenza A virus | 4 | 2025 | 120 | 0.530 |
Why?
| | Host Specificity | 7 | 2025 | 33 | 0.530 |
Why?
| | Evoked Potentials | 2 | 2018 | 134 | 0.520 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4580 | 0.520 |
Why?
| | High-Throughput Nucleotide Sequencing | 8 | 2020 | 539 | 0.500 |
Why?
| | Reaction Time | 2 | 2018 | 438 | 0.500 |
Why?
| | Bird Diseases | 2 | 2016 | 16 | 0.500 |
Why?
| | Ticks | 6 | 2025 | 30 | 0.490 |
Why?
| | Male | 57 | 2026 | 73396 | 0.490 |
Why?
| | Societies, Scientific | 2 | 2017 | 51 | 0.490 |
Why?
| | Endocytosis | 2 | 2014 | 170 | 0.480 |
Why?
| | Reverse Genetics | 4 | 2021 | 7 | 0.480 |
Why?
| | Neglected Diseases | 1 | 2016 | 5 | 0.480 |
Why?
| | Borna Disease | 2 | 2021 | 2 | 0.480 |
Why?
| | Colobus | 1 | 2016 | 3 | 0.470 |
Why?
| | Retroviridae | 4 | 2025 | 99 | 0.470 |
Why?
| | Cognitive Dysfunction | 1 | 2022 | 481 | 0.460 |
Why?
| | Dogs | 2 | 2015 | 517 | 0.460 |
Why?
| | Dipeptidyl Peptidase 4 | 2 | 2016 | 15 | 0.460 |
Why?
| | Subthalamic Nucleus | 4 | 2026 | 85 | 0.460 |
Why?
| | HEK293 Cells | 11 | 2025 | 750 | 0.460 |
Why?
| | Hospitals, Psychiatric | 1 | 2015 | 25 | 0.460 |
Why?
| | Laboratories | 4 | 2016 | 109 | 0.450 |
Why?
| | Animal Assisted Therapy | 1 | 2015 | 12 | 0.450 |
Why?
| | Africa | 8 | 2021 | 119 | 0.450 |
Why?
| | Psychomotor Performance | 1 | 2018 | 329 | 0.440 |
Why?
| | Cricetinae | 7 | 2026 | 296 | 0.440 |
Why?
| | DNA, Viral | 5 | 2026 | 354 | 0.440 |
Why?
| | Hospitals, University | 1 | 2015 | 178 | 0.440 |
Why?
| | Communicable Diseases | 2 | 2014 | 166 | 0.430 |
Why?
| | Tics | 3 | 2024 | 6 | 0.430 |
Why?
| | Reflex, Startle | 2 | 2020 | 75 | 0.430 |
Why?
| | Female | 53 | 2026 | 79499 | 0.430 |
Why?
| | Insecta | 3 | 2024 | 73 | 0.430 |
Why?
| | Cytopathogenic Effect, Viral | 3 | 2026 | 17 | 0.430 |
Why?
| | Nematoda | 2 | 2017 | 12 | 0.420 |
Why?
| | Depressive Disorder | 2 | 2015 | 361 | 0.420 |
Why?
| | Tic Disorders | 1 | 2014 | 10 | 0.420 |
Why?
| | Asymptomatic Infections | 4 | 2018 | 40 | 0.410 |
Why?
| | Plant Viruses | 3 | 2025 | 12 | 0.400 |
Why?
| | Molecular Sequence Data | 16 | 2015 | 2838 | 0.400 |
Why?
| | Reassortant Viruses | 1 | 2013 | 8 | 0.400 |
Why?
| | Aerosols | 5 | 2026 | 146 | 0.400 |
Why?
| | Virus Release | 5 | 2020 | 8 | 0.400 |
Why?
| | Magnetic Resonance Imaging | 9 | 2025 | 3926 | 0.390 |
Why?
| | Communicable Disease Control | 1 | 2014 | 88 | 0.390 |
Why?
| | Cluster Analysis | 9 | 2019 | 496 | 0.390 |
Why?
| | Viral Load | 6 | 2020 | 526 | 0.380 |
Why?
| | Mesocricetus | 5 | 2026 | 47 | 0.380 |
Why?
| | Positron Emission Tomography Computed Tomography | 2 | 2026 | 122 | 0.380 |
Why?
| | Animals, Laboratory | 1 | 2013 | 22 | 0.380 |
Why?
| | Neural Pathways | 4 | 2026 | 319 | 0.360 |
Why?
| | Infectious bronchitis virus | 3 | 2017 | 3 | 0.360 |
Why?
| | Treatment Outcome | 13 | 2023 | 11821 | 0.360 |
Why?
| | Zoonoses | 4 | 2022 | 39 | 0.360 |
Why?
| | Viruses, Unclassified | 2 | 2022 | 4 | 0.350 |
Why?
| | Suicide, Attempted | 2 | 2026 | 391 | 0.350 |
Why?
| | Bioterrorism | 1 | 2011 | 31 | 0.340 |
Why?
| | Capsid Proteins | 4 | 2025 | 94 | 0.340 |
Why?
| | Safety | 4 | 2016 | 347 | 0.340 |
Why?
| | Peptidyl-Dipeptidase A | 4 | 2007 | 57 | 0.330 |
Why?
| | Autistic Disorder | 1 | 2014 | 216 | 0.330 |
Why?
| | Occupational Health | 1 | 2014 | 212 | 0.330 |
Why?
| | Specimen Handling | 3 | 2025 | 178 | 0.330 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2011 | 41 | 0.330 |
Why?
| | Immunoglobulin G | 4 | 2026 | 901 | 0.330 |
Why?
| | Adult | 28 | 2026 | 41087 | 0.320 |
Why?
| | Sequence Alignment | 7 | 2020 | 360 | 0.320 |
Why?
| | Viral Tropism | 3 | 2026 | 38 | 0.320 |
Why?
| | Bacteriophages | 3 | 2023 | 110 | 0.310 |
Why?
| | Animals, Wild | 4 | 2020 | 64 | 0.310 |
Why?
| | Suicidal Ideation | 2 | 2026 | 543 | 0.310 |
Why?
| | Plasmids | 2 | 2021 | 373 | 0.310 |
Why?
| | Neuroimaging | 2 | 2025 | 307 | 0.310 |
Why?
| | Guinea Pigs | 8 | 2026 | 159 | 0.310 |
Why?
| | Beta Rhythm | 2 | 2024 | 33 | 0.310 |
Why?
| | Nervous System Diseases | 2 | 2010 | 288 | 0.300 |
Why?
| | Sequence Homology | 4 | 2017 | 43 | 0.300 |
Why?
| | Animal Diseases | 2 | 2022 | 9 | 0.290 |
Why?
| | Genotype | 6 | 2022 | 1879 | 0.290 |
Why?
| | Anticipation, Genetic | 1 | 2008 | 1 | 0.290 |
Why?
| | Spinal Cord Vascular Diseases | 1 | 2008 | 5 | 0.290 |
Why?
| | RNA | 5 | 2023 | 926 | 0.290 |
Why?
| | Virulence | 4 | 2024 | 288 | 0.280 |
Why?
| | Pandemics | 5 | 2021 | 1707 | 0.280 |
Why?
| | Young Adult | 12 | 2026 | 14330 | 0.280 |
Why?
| | Neuropsychological Tests | 4 | 2021 | 1149 | 0.280 |
Why?
| | Mental Disorders | 2 | 2026 | 1148 | 0.280 |
Why?
| | Mice | 18 | 2025 | 18297 | 0.280 |
Why?
| | Antidepressive Agents | 2 | 2021 | 235 | 0.270 |
Why?
| | Electroencephalography | 6 | 2025 | 576 | 0.270 |
Why?
| | Middle Aged | 22 | 2026 | 36619 | 0.270 |
Why?
| | Cerebrovascular Disorders | 1 | 2008 | 103 | 0.260 |
Why?
| | Pick Disease of the Brain | 1 | 2007 | 4 | 0.260 |
Why?
| | Africa, Western | 4 | 2020 | 21 | 0.260 |
Why?
| | Bayes Theorem | 4 | 2023 | 426 | 0.250 |
Why?
| | Medial Forebrain Bundle | 1 | 2026 | 1 | 0.250 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2017 | 522 | 0.250 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2018 | 382 | 0.250 |
Why?
| | Positron-Emission Tomography | 3 | 2022 | 343 | 0.240 |
Why?
| | Amino Acid Substitution | 2 | 2026 | 297 | 0.240 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 4 | 2014 | 25 | 0.240 |
Why?
| | Depressive Disorder, Treatment-Resistant | 2 | 2017 | 14 | 0.240 |
Why?
| | Security Measures | 1 | 2026 | 7 | 0.240 |
Why?
| | Virus Cultivation | 2 | 2018 | 31 | 0.240 |
Why?
| | Whole Genome Sequencing | 4 | 2025 | 183 | 0.240 |
Why?
| | Aotidae | 1 | 2026 | 11 | 0.230 |
Why?
| | ADP-Ribosylation | 1 | 2025 | 1 | 0.230 |
Why?
| | Gyrus Cinguli | 2 | 2017 | 98 | 0.230 |
Why?
| | Viremia | 2 | 2025 | 158 | 0.230 |
Why?
| | Spinal Cord | 1 | 2008 | 378 | 0.230 |
Why?
| | Rumination, Cognitive | 1 | 2026 | 11 | 0.230 |
Why?
| | Replicon | 1 | 2025 | 12 | 0.230 |
Why?
| | Species Specificity | 2 | 2017 | 543 | 0.230 |
Why?
| | Metacognition | 1 | 2026 | 17 | 0.230 |
Why?
| | Toxicity Tests | 2 | 2016 | 53 | 0.230 |
Why?
| | High-Throughput Screening Assays | 2 | 2026 | 179 | 0.230 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2026 | 33 | 0.230 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2026 | 164 | 0.230 |
Why?
| | Receptors, CXCR4 | 1 | 2026 | 91 | 0.230 |
Why?
| | RNA Helicases | 1 | 2025 | 31 | 0.230 |
Why?
| | Nucleocapsid Proteins | 3 | 2020 | 28 | 0.220 |
Why?
| | Germany | 4 | 2020 | 139 | 0.220 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2025 | 55 | 0.220 |
Why?
| | Genes, Viral | 3 | 2020 | 88 | 0.220 |
Why?
| | Virus Inactivation | 1 | 2025 | 13 | 0.220 |
Why?
| | Nerve Net | 4 | 2025 | 286 | 0.220 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 387 | 0.220 |
Why?
| | Dengue Virus | 1 | 2025 | 62 | 0.220 |
Why?
| | Respiratory System | 1 | 2026 | 150 | 0.210 |
Why?
| | Clinical Laboratory Techniques | 3 | 2020 | 96 | 0.210 |
Why?
| | Immunity, Humoral | 1 | 2025 | 121 | 0.210 |
Why?
| | Fungal Viruses | 1 | 2024 | 1 | 0.210 |
Why?
| | Liberia | 6 | 2025 | 15 | 0.210 |
Why?
| | Schizophrenia | 2 | 2019 | 537 | 0.210 |
Why?
| | Vaccination | 6 | 2026 | 1449 | 0.210 |
Why?
| | Poxviridae | 1 | 2024 | 3 | 0.210 |
Why?
| | Orthopoxvirus | 1 | 2024 | 4 | 0.210 |
Why?
| | Tenuivirus | 1 | 2024 | 1 | 0.210 |
Why?
| | Drug Discovery | 3 | 2015 | 154 | 0.210 |
Why?
| | Immunization, Secondary | 1 | 2024 | 94 | 0.210 |
Why?
| | Hemiptera | 1 | 2024 | 5 | 0.210 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 163 | 0.200 |
Why?
| | Ficus | 1 | 2024 | 2 | 0.200 |
Why?
| | One Health | 2 | 2021 | 10 | 0.200 |
Why?
| | History, 20th Century | 5 | 2020 | 330 | 0.200 |
Why?
| | Rodentia | 2 | 2021 | 63 | 0.200 |
Why?
| | Base Sequence | 6 | 2017 | 2123 | 0.200 |
Why?
| | Models, Molecular | 9 | 2024 | 1573 | 0.200 |
Why?
| | Lactate dehydrogenase-elevating virus | 1 | 2023 | 1 | 0.200 |
Why?
| | Proof of Concept Study | 2 | 2021 | 90 | 0.200 |
Why?
| | Oryza | 1 | 2024 | 34 | 0.200 |
Why?
| | Ectopic Gene Expression | 1 | 2023 | 5 | 0.200 |
Why?
| | Crustacea | 1 | 2023 | 5 | 0.200 |
Why?
| | Immunohistochemistry | 4 | 2020 | 1712 | 0.200 |
Why?
| | DNA Transposable Elements | 1 | 2024 | 125 | 0.200 |
Why?
| | Uganda | 3 | 2020 | 91 | 0.190 |
Why?
| | Quality of Life | 6 | 2023 | 3200 | 0.190 |
Why?
| | Fungi | 1 | 2024 | 120 | 0.190 |
Why?
| | Public Health Surveillance | 2 | 2021 | 84 | 0.190 |
Why?
| | Dementia | 1 | 2007 | 324 | 0.190 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2020 | 92 | 0.190 |
Why?
| | Drug Design | 1 | 2024 | 180 | 0.190 |
Why?
| | Disinfectants | 1 | 2023 | 45 | 0.190 |
Why?
| | Electrodes, Implanted | 2 | 2020 | 114 | 0.190 |
Why?
| | Adolescent | 10 | 2026 | 22557 | 0.190 |
Why?
| | Frameshifting, Ribosomal | 2 | 2019 | 9 | 0.180 |
Why?
| | Biological Products | 2 | 2020 | 258 | 0.180 |
Why?
| | Vaccines, Attenuated | 2 | 2020 | 129 | 0.180 |
Why?
| | Plankton | 1 | 2022 | 8 | 0.180 |
Why?
| | Cell Culture Techniques | 2 | 2023 | 371 | 0.180 |
Why?
| | Democratic Republic of the Congo | 3 | 2019 | 33 | 0.180 |
Why?
| | Seawater | 1 | 2022 | 33 | 0.180 |
Why?
| | Virus Physiological Phenomena | 2 | 2020 | 9 | 0.180 |
Why?
| | Viral Plaque Assay | 2 | 2025 | 29 | 0.180 |
Why?
| | Follow-Up Studies | 7 | 2020 | 5439 | 0.180 |
Why?
| | Antigens, Differentiation | 2 | 2013 | 75 | 0.180 |
Why?
| | Cowpox virus | 1 | 2021 | 2 | 0.170 |
Why?
| | Fish Diseases | 1 | 2021 | 18 | 0.170 |
Why?
| | Ribavirin | 2 | 2020 | 81 | 0.170 |
Why?
| | Hepacivirus | 1 | 2023 | 237 | 0.170 |
Why?
| | Borna disease virus | 1 | 2021 | 1 | 0.170 |
Why?
| | Smallpox | 1 | 2021 | 10 | 0.170 |
Why?
| | HIV-1 | 3 | 2026 | 913 | 0.170 |
Why?
| | Dicistroviridae | 1 | 2021 | 7 | 0.170 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2019 | 36 | 0.170 |
Why?
| | Sarcina | 1 | 2021 | 1 | 0.170 |
Why?
| | Proteome | 2 | 2018 | 520 | 0.170 |
Why?
| | Fluvoxamine | 1 | 2021 | 18 | 0.170 |
Why?
| | Papio | 2 | 2018 | 71 | 0.170 |
Why?
| | Uveitis | 1 | 2022 | 152 | 0.170 |
Why?
| | Ape Diseases | 1 | 2021 | 7 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2026 | 778 | 0.160 |
Why?
| | Rubella virus | 1 | 2020 | 7 | 0.160 |
Why?
| | Plant Diseases | 2 | 2024 | 44 | 0.160 |
Why?
| | Addiction Medicine | 1 | 2021 | 14 | 0.160 |
Why?
| | RNA, Small Interfering | 4 | 2016 | 633 | 0.160 |
Why?
| | Phlebovirus | 1 | 2020 | 6 | 0.160 |
Why?
| | Anti-Infective Agents | 1 | 2023 | 234 | 0.160 |
Why?
| | Immunotoxins | 1 | 2021 | 51 | 0.160 |
Why?
| | DNA Mutational Analysis | 5 | 2017 | 410 | 0.160 |
Why?
| | Reward | 2 | 2020 | 242 | 0.160 |
Why?
| | Laboratory Infection | 1 | 2020 | 1 | 0.160 |
Why?
| | DNA Replication | 2 | 2020 | 248 | 0.160 |
Why?
| | Bunyaviridae Infections | 1 | 2020 | 15 | 0.160 |
Why?
| | DNA, Circular | 1 | 2020 | 15 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 288 | 0.160 |
Why?
| | Mutation | 9 | 2025 | 4093 | 0.160 |
Why?
| | Carrier State | 2 | 2020 | 80 | 0.160 |
Why?
| | RNA Polymerase II | 1 | 2024 | 347 | 0.160 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2020 | 27 | 0.160 |
Why?
| | Clinical Trials as Topic | 2 | 2016 | 1064 | 0.160 |
Why?
| | Myocarditis | 1 | 2021 | 103 | 0.160 |
Why?
| | Semen | 2 | 2021 | 21 | 0.160 |
Why?
| | Hominidae | 1 | 2021 | 89 | 0.160 |
Why?
| | Caudovirales | 1 | 2020 | 1 | 0.150 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2021 | 72 | 0.150 |
Why?
| | DNA, Intergenic | 1 | 2020 | 25 | 0.150 |
Why?
| | Eukaryota | 3 | 2025 | 56 | 0.150 |
Why?
| | Cell Line, Tumor | 4 | 2022 | 3545 | 0.150 |
Why?
| | Child Abuse | 1 | 2026 | 545 | 0.150 |
Why?
| | Emphysema | 1 | 2021 | 100 | 0.150 |
Why?
| | Arenavirus | 2 | 2020 | 3 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 974 | 0.150 |
Why?
| | Liver Diseases | 1 | 2023 | 304 | 0.150 |
Why?
| | Sequence Analysis, RNA | 3 | 2018 | 441 | 0.150 |
Why?
| | Porcine respiratory and reproductive syndrome virus | 1 | 2019 | 1 | 0.150 |
Why?
| | Gastritis | 1 | 2021 | 117 | 0.150 |
Why?
| | In Situ Hybridization | 2 | 2020 | 317 | 0.150 |
Why?
| | Respiration | 2 | 2018 | 208 | 0.150 |
Why?
| | Databases, Pharmaceutical | 1 | 2019 | 6 | 0.150 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 345 | 0.150 |
Why?
| | Influenza, Human | 1 | 2025 | 640 | 0.150 |
Why?
| | Computational Biology | 5 | 2026 | 678 | 0.150 |
Why?
| | Molecular Structure | 1 | 2020 | 484 | 0.150 |
Why?
| | A549 Cells | 4 | 2020 | 76 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 2022 | 0.150 |
Why?
| | Internationality | 3 | 2017 | 156 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 5 | 2025 | 846 | 0.150 |
Why?
| | Drug Repositioning | 1 | 2019 | 41 | 0.150 |
Why?
| | DNA, Single-Stranded | 1 | 2020 | 119 | 0.140 |
Why?
| | Gene Rearrangement | 1 | 2020 | 156 | 0.140 |
Why?
| | Neuronavigation | 1 | 2019 | 8 | 0.140 |
Why?
| | Guinea | 2 | 2018 | 3 | 0.140 |
Why?
| | Ixodidae | 1 | 2019 | 7 | 0.140 |
Why?
| | Phage Therapy | 1 | 2019 | 17 | 0.140 |
Why?
| | Fluorometry | 1 | 2018 | 19 | 0.140 |
Why?
| | Tiletamine | 1 | 2018 | 2 | 0.140 |
Why?
| | Zolazepam | 1 | 2018 | 2 | 0.140 |
Why?
| | Shrews | 1 | 2018 | 4 | 0.140 |
Why?
| | Hepadnaviridae | 1 | 2018 | 1 | 0.140 |
Why?
| | Caulimoviridae | 1 | 2018 | 1 | 0.140 |
Why?
| | Immobilization | 1 | 2018 | 54 | 0.140 |
Why?
| | Cell Survival | 1 | 2022 | 1105 | 0.140 |
Why?
| | Aging | 2 | 2025 | 1996 | 0.140 |
Why?
| | Mononegavirales Infections | 1 | 2018 | 1 | 0.140 |
Why?
| | Cerebral Cortex | 2 | 2024 | 485 | 0.140 |
Why?
| | Time Factors | 5 | 2026 | 7109 | 0.140 |
Why?
| | Midazolam | 1 | 2018 | 69 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2020 | 138 | 0.140 |
Why?
| | Spumavirus | 1 | 2018 | 3 | 0.140 |
Why?
| | Models, Neurological | 1 | 2020 | 252 | 0.130 |
Why?
| | Cell Membrane | 2 | 2020 | 701 | 0.130 |
Why?
| | Schizophrenic Psychology | 1 | 2018 | 121 | 0.130 |
Why?
| | Severe Acute Respiratory Syndrome | 3 | 2007 | 19 | 0.130 |
Why?
| | Committee Membership | 3 | 2023 | 5 | 0.130 |
Why?
| | Genomic Instability | 1 | 2018 | 64 | 0.130 |
Why?
| | Double-Blind Method | 4 | 2026 | 2070 | 0.130 |
Why?
| | Encephalomyocarditis virus | 1 | 2017 | 1 | 0.130 |
Why?
| | Papio hamadryas | 1 | 2017 | 3 | 0.130 |
Why?
| | Cardiovirus Infections | 1 | 2017 | 3 | 0.130 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2018 | 25 | 0.130 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 54 | 0.130 |
Why?
| | Boidae | 1 | 2018 | 37 | 0.130 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 55 | 0.130 |
Why?
| | Testis | 1 | 2018 | 158 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2021 | 561 | 0.130 |
Why?
| | Motivational Interviewing | 1 | 2019 | 121 | 0.130 |
Why?
| | Retroviridae Infections | 1 | 2018 | 47 | 0.130 |
Why?
| | Amino Acids | 2 | 2020 | 515 | 0.130 |
Why?
| | Biotechnology | 1 | 2018 | 45 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 2 | 2025 | 487 | 0.130 |
Why?
| | MicroRNAs | 1 | 2024 | 699 | 0.130 |
Why?
| | Software Design | 1 | 2017 | 25 | 0.130 |
Why?
| | Gene Order | 1 | 2017 | 29 | 0.130 |
Why?
| | Acoustic Stimulation | 2 | 2020 | 325 | 0.130 |
Why?
| | Maryland | 2 | 2014 | 67 | 0.130 |
Why?
| | Outpatients | 1 | 2021 | 440 | 0.130 |
Why?
| | Poultry Diseases | 1 | 2017 | 13 | 0.130 |
Why?
| | Dopamine | 1 | 2020 | 295 | 0.130 |
Why?
| | Diptera | 1 | 2017 | 31 | 0.130 |
Why?
| | Spike Glycoprotein, Coronavirus | 5 | 2017 | 129 | 0.130 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 823 | 0.120 |
Why?
| | Birds | 2 | 2017 | 87 | 0.120 |
Why?
| | Encephalitis Virus, Venezuelan Equine | 1 | 2016 | 6 | 0.120 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.120 |
Why?
| | Flaviviridae Infections | 1 | 2016 | 2 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 4 | 2023 | 2786 | 0.120 |
Why?
| | Zika Virus | 1 | 2018 | 137 | 0.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 429 | 0.120 |
Why?
| | Protective Clothing | 1 | 2016 | 15 | 0.120 |
Why?
| | Lentivirus Infections | 1 | 2016 | 9 | 0.120 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.120 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2016 | 39 | 0.120 |
Why?
| | Gene Regulatory Networks | 1 | 2019 | 319 | 0.120 |
Why?
| | Polymerase Chain Reaction | 2 | 2017 | 1031 | 0.120 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2016 | 26 | 0.120 |
Why?
| | Viral Nonstructural Proteins | 3 | 2025 | 64 | 0.120 |
Why?
| | Aged | 9 | 2021 | 26432 | 0.120 |
Why?
| | Functional Laterality | 1 | 2017 | 242 | 0.120 |
Why?
| | Alphavirus | 1 | 2016 | 22 | 0.120 |
Why?
| | Chromosomes, Mammalian | 1 | 2016 | 28 | 0.120 |
Why?
| | Plants | 3 | 2025 | 168 | 0.120 |
Why?
| | Virus Attachment | 1 | 2015 | 19 | 0.120 |
Why?
| | Immunoassay | 1 | 2016 | 108 | 0.120 |
Why?
| | Selection, Genetic | 2 | 2017 | 269 | 0.120 |
Why?
| | Macrophages | 4 | 2024 | 1532 | 0.120 |
Why?
| | Satellite Viruses | 1 | 2015 | 1 | 0.120 |
Why?
| | Extracellular Vesicles | 1 | 2018 | 176 | 0.120 |
Why?
| | Orthobunyavirus | 1 | 2015 | 8 | 0.120 |
Why?
| | Hemorrhage | 1 | 2021 | 825 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2016 | 140 | 0.110 |
Why?
| | Protein Binding | 7 | 2018 | 2244 | 0.110 |
Why?
| | Alcoholism | 1 | 2023 | 830 | 0.110 |
Why?
| | Zika Virus Infection | 1 | 2018 | 174 | 0.110 |
Why?
| | Alphavirus Infections | 1 | 2016 | 45 | 0.110 |
Why?
| | Cell Cycle | 1 | 2018 | 595 | 0.110 |
Why?
| | Skin | 1 | 2020 | 701 | 0.110 |
Why?
| | Learning | 1 | 2020 | 446 | 0.110 |
Why?
| | Italy | 2 | 2025 | 118 | 0.110 |
Why?
| | Immunization, Passive | 1 | 2015 | 90 | 0.110 |
Why?
| | Rabbits | 3 | 2020 | 651 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2020 | 578 | 0.110 |
Why?
| | Lung | 3 | 2026 | 4122 | 0.110 |
Why?
| | Carboxypeptidases | 2 | 2005 | 12 | 0.110 |
Why?
| | Immune Evasion | 1 | 2015 | 64 | 0.110 |
Why?
| | Epitopes | 3 | 2025 | 479 | 0.110 |
Why?
| | Cysteine Proteases | 1 | 2014 | 8 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2015 | 79 | 0.110 |
Why?
| | DNA | 1 | 2021 | 1421 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2018 | 430 | 0.100 |
Why?
| | Physician-Patient Relations | 1 | 2019 | 597 | 0.100 |
Why?
| | RNA Interference | 2 | 2016 | 472 | 0.100 |
Why?
| | Compulsive Behavior | 1 | 2014 | 6 | 0.100 |
Why?
| | Animal Experimentation | 1 | 2014 | 8 | 0.100 |
Why?
| | Veterinary Medicine | 1 | 2014 | 12 | 0.100 |
Why?
| | Asia | 3 | 2023 | 69 | 0.100 |
Why?
| | Adaptation, Biological | 1 | 2014 | 48 | 0.100 |
Why?
| | Substance-Related Disorders | 2 | 2021 | 1100 | 0.100 |
Why?
| | Retrospective Studies | 9 | 2026 | 17438 | 0.100 |
Why?
| | Dopamine Agonists | 1 | 2014 | 41 | 0.100 |
Why?
| | Animals, Zoo | 3 | 2020 | 17 | 0.100 |
Why?
| | Endosomes | 2 | 2014 | 139 | 0.100 |
Why?
| | Optical Imaging | 1 | 2014 | 63 | 0.100 |
Why?
| | Forecasting | 1 | 2015 | 388 | 0.100 |
Why?
| | Comorbidity | 2 | 2020 | 1665 | 0.100 |
Why?
| | Habituation, Psychophysiologic | 1 | 2014 | 58 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 634 | 0.100 |
Why?
| | Clathrin-Coated Vesicles | 1 | 2013 | 5 | 0.100 |
Why?
| | Rift Valley fever virus | 1 | 2013 | 3 | 0.100 |
Why?
| | Hepatocytes | 1 | 2014 | 224 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2025 | 1130 | 0.100 |
Why?
| | Molecular Epidemiology | 3 | 2020 | 74 | 0.100 |
Why?
| | Clathrin | 1 | 2013 | 26 | 0.100 |
Why?
| | Nucleic Acid Conformation | 1 | 2016 | 724 | 0.100 |
Why?
| | Psychometrics | 1 | 2017 | 712 | 0.100 |
Why?
| | Inhalation Exposure | 1 | 2014 | 103 | 0.090 |
Why?
| | Tissue Culture Techniques | 1 | 2013 | 82 | 0.090 |
Why?
| | Perception | 1 | 2016 | 373 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 339 | 0.090 |
Why?
| | Empathy | 1 | 2015 | 184 | 0.090 |
Why?
| | Survivors | 3 | 2022 | 526 | 0.090 |
Why?
| | United States | 6 | 2024 | 16136 | 0.090 |
Why?
| | Neural Inhibition | 1 | 2014 | 186 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 384 | 0.090 |
Why?
| | Oceans and Seas | 2 | 2022 | 22 | 0.090 |
Why?
| | Emotions | 2 | 2015 | 559 | 0.090 |
Why?
| | Self Concept | 1 | 2014 | 257 | 0.090 |
Why?
| | Virosomes | 1 | 2012 | 2 | 0.090 |
Why?
| | Protein Kinases | 1 | 2014 | 311 | 0.090 |
Why?
| | Cross Reactions | 1 | 2012 | 130 | 0.090 |
Why?
| | Diagnostic Errors | 2 | 2017 | 178 | 0.090 |
Why?
| | Global Health | 2 | 2021 | 403 | 0.090 |
Why?
| | Cell Movement | 1 | 2016 | 951 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 455 | 0.080 |
Why?
| | Liver | 2 | 2018 | 1864 | 0.080 |
Why?
| | Bipolar Disorder | 1 | 2014 | 285 | 0.080 |
Why?
| | Protein Transport | 2 | 2026 | 443 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 663 | 0.080 |
Why?
| | Invertebrates | 2 | 2021 | 21 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2014 | 728 | 0.080 |
Why?
| | HIV Infections | 1 | 2026 | 3215 | 0.080 |
Why?
| | Models, Animal | 2 | 2023 | 387 | 0.080 |
Why?
| | Particle Size | 2 | 2026 | 386 | 0.080 |
Why?
| | Immunity, Innate | 2 | 2026 | 844 | 0.080 |
Why?
| | Cattle | 2 | 2016 | 940 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2021 | 2240 | 0.070 |
Why?
| | Prevalence | 4 | 2019 | 2861 | 0.070 |
Why?
| | Europe | 2 | 2025 | 421 | 0.070 |
Why?
| | Algorithms | 1 | 2017 | 1849 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 465 | 0.070 |
Why?
| | Viral Fusion Proteins | 1 | 2009 | 21 | 0.070 |
Why?
| | Frameshift Mutation | 1 | 2008 | 32 | 0.070 |
Why?
| | Fibroblasts | 1 | 2014 | 1034 | 0.070 |
Why?
| | Granulocytes | 1 | 2008 | 82 | 0.070 |
Why?
| | Protein Structure, Tertiary | 4 | 2014 | 834 | 0.070 |
Why?
| | Sierra Leone | 2 | 2021 | 3 | 0.070 |
Why?
| | Sensory Gating | 2 | 2020 | 45 | 0.070 |
Why?
| | Ceruloplasmin | 1 | 2008 | 10 | 0.070 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2008 | 6 | 0.070 |
Why?
| | History, 21st Century | 3 | 2017 | 224 | 0.070 |
Why?
| | Up-Regulation | 2 | 2024 | 841 | 0.070 |
Why?
| | Interferons | 2 | 2020 | 186 | 0.070 |
Why?
| | Child | 3 | 2026 | 22693 | 0.070 |
Why?
| | Communication | 3 | 2021 | 980 | 0.070 |
Why?
| | Virus Assembly | 2 | 2020 | 81 | 0.070 |
Why?
| | Binding Sites | 5 | 2011 | 1309 | 0.070 |
Why?
| | Prospective Studies | 2 | 2026 | 8123 | 0.070 |
Why?
| | Brain Mapping | 2 | 2025 | 541 | 0.070 |
Why?
| | Rehabilitation, Vocational | 1 | 2007 | 6 | 0.070 |
Why?
| | Bacteria | 2 | 2025 | 766 | 0.070 |
Why?
| | Dominance, Cerebral | 1 | 2007 | 57 | 0.070 |
Why?
| | Amino Acid Motifs | 2 | 2019 | 218 | 0.070 |
Why?
| | Ecosystem | 2 | 2022 | 483 | 0.070 |
Why?
| | Coronavirus 229E, Human | 1 | 2007 | 7 | 0.060 |
Why?
| | Pedigree | 1 | 2008 | 512 | 0.060 |
Why?
| | Recurrence | 2 | 2022 | 1133 | 0.060 |
Why?
| | Phenotype | 2 | 2021 | 3206 | 0.060 |
Why?
| | Atrophy | 1 | 2007 | 199 | 0.060 |
Why?
| | Temporal Lobe | 1 | 2007 | 112 | 0.060 |
Why?
| | Morocco | 2 | 2017 | 3 | 0.060 |
Why?
| | Russia | 3 | 2017 | 12 | 0.060 |
Why?
| | Lymphocytes | 1 | 2008 | 379 | 0.060 |
Why?
| | Science | 1 | 2007 | 55 | 0.060 |
Why?
| | Anxiety | 1 | 2014 | 1125 | 0.060 |
Why?
| | Golgi Apparatus | 1 | 2026 | 99 | 0.060 |
Why?
| | Cats | 1 | 2007 | 226 | 0.060 |
Why?
| | Memory Disorders | 1 | 2007 | 198 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2014 | 3647 | 0.060 |
Why?
| | Diffusion Tensor Imaging | 1 | 2026 | 83 | 0.060 |
Why?
| | Vaccines, Synthetic | 2 | 2020 | 138 | 0.060 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2025 | 5 | 0.060 |
Why?
| | Haplorhini | 2 | 2016 | 51 | 0.060 |
Why?
| | Immunocompetence | 1 | 2026 | 46 | 0.060 |
Why?
| | Hexosyltransferases | 1 | 2025 | 6 | 0.060 |
Why?
| | Jurkat Cells | 1 | 2006 | 115 | 0.060 |
Why?
| | Pyrimidines | 2 | 2020 | 532 | 0.060 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2025 | 17 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2599 | 0.060 |
Why?
| | Administration, Intranasal | 1 | 2026 | 95 | 0.060 |
Why?
| | Alpha Rhythm | 1 | 2025 | 11 | 0.060 |
Why?
| | Policy Making | 1 | 2026 | 83 | 0.060 |
Why?
| | Comprehension | 1 | 2007 | 175 | 0.060 |
Why?
| | Vesiculovirus | 1 | 2025 | 17 | 0.060 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2025 | 36 | 0.060 |
Why?
| | CD4 Antigens | 1 | 2026 | 136 | 0.060 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2017 | 150 | 0.060 |
Why?
| | Research Personnel | 1 | 2007 | 190 | 0.060 |
Why?
| | Chickens | 2 | 2016 | 169 | 0.060 |
Why?
| | Ecological Momentary Assessment | 1 | 2026 | 50 | 0.060 |
Why?
| | Seroepidemiologic Studies | 1 | 2025 | 171 | 0.060 |
Why?
| | Gene Knockout Techniques | 1 | 2025 | 122 | 0.060 |
Why?
| | Telomere | 1 | 2008 | 300 | 0.060 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2026 | 158 | 0.050 |
Why?
| | Peptides | 1 | 2011 | 992 | 0.050 |
Why?
| | Coronaviridae | 1 | 2024 | 4 | 0.050 |
Why?
| | Phylogeography | 2 | 2015 | 52 | 0.050 |
Why?
| | Hospitalization | 1 | 2015 | 2475 | 0.050 |
Why?
| | Ribonucleoproteins | 2 | 2019 | 106 | 0.050 |
Why?
| | Leukemia Virus, Murine | 1 | 2004 | 17 | 0.050 |
Why?
| | Gray Matter | 1 | 2025 | 96 | 0.050 |
Why?
| | Caregivers | 1 | 2014 | 1080 | 0.050 |
Why?
| | Chikungunya virus | 1 | 2025 | 81 | 0.050 |
Why?
| | Administration, Inhalation | 2 | 2016 | 567 | 0.050 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1271 | 0.050 |
Why?
| | Immunogenicity, Vaccine | 1 | 2024 | 42 | 0.050 |
Why?
| | Fibrillin-2 | 1 | 2024 | 2 | 0.050 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2024 | 48 | 0.050 |
Why?
| | Virus Integration | 1 | 2024 | 69 | 0.050 |
Why?
| | Astrocytes | 1 | 2026 | 229 | 0.050 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2004 | 94 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 182 | 0.050 |
Why?
| | Family | 1 | 2008 | 690 | 0.050 |
Why?
| | Immunity, Cellular | 2 | 2018 | 277 | 0.050 |
Why?
| | Attention | 1 | 2007 | 463 | 0.050 |
Why?
| | Heart | 2 | 2018 | 626 | 0.050 |
Why?
| | Pollination | 1 | 2024 | 22 | 0.050 |
Why?
| | Antibody Formation | 1 | 2024 | 290 | 0.050 |
Why?
| | Crystallography, X-Ray | 1 | 2025 | 477 | 0.050 |
Why?
| | Microglia | 1 | 2026 | 289 | 0.050 |
Why?
| | Disease Progression | 2 | 2023 | 2867 | 0.050 |
Why?
| | Canada | 1 | 2024 | 432 | 0.050 |
Why?
| | Fruit | 1 | 2024 | 144 | 0.050 |
Why?
| | Anhedonia | 1 | 2023 | 18 | 0.050 |
Why?
| | Anesthesia | 2 | 2016 | 257 | 0.050 |
Why?
| | Ecology | 1 | 2024 | 106 | 0.050 |
Why?
| | Glycosylation | 2 | 2016 | 177 | 0.050 |
Why?
| | Carbon Cycle | 1 | 2022 | 13 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2006 | 411 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2016 | 1298 | 0.040 |
Why?
| | Livestock | 1 | 2022 | 9 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3416 | 0.040 |
Why?
| | Switzerland | 1 | 2021 | 45 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2022 | 167 | 0.040 |
Why?
| | Fresh Water | 1 | 2021 | 53 | 0.040 |
Why?
| | Pupa | 1 | 2021 | 14 | 0.040 |
Why?
| | Inpatients | 1 | 2026 | 540 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2016 | 1244 | 0.040 |
Why?
| | Protein Subunits | 1 | 2022 | 225 | 0.040 |
Why?
| | Argentina | 1 | 2020 | 28 | 0.040 |
Why?
| | Rats | 2 | 2007 | 5586 | 0.040 |
Why?
| | Marsupialia | 1 | 2020 | 8 | 0.040 |
Why?
| | Equidae | 1 | 2020 | 7 | 0.040 |
Why?
| | Chromogenic Compounds | 1 | 2020 | 4 | 0.040 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2020 | 20 | 0.040 |
Why?
| | Republic of Korea | 1 | 2020 | 43 | 0.040 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 16 | 0.040 |
Why?
| | Membrane Fusion | 1 | 2020 | 40 | 0.040 |
Why?
| | Genome Size | 1 | 2020 | 9 | 0.040 |
Why?
| | Prepulse Inhibition | 1 | 2020 | 12 | 0.040 |
Why?
| | Geographic Mapping | 1 | 2020 | 26 | 0.040 |
Why?
| | Writing | 1 | 2022 | 101 | 0.040 |
Why?
| | Ferrets | 1 | 2020 | 32 | 0.040 |
Why?
| | Yugoslavia | 1 | 2020 | 4 | 0.040 |
Why?
| | Biomarkers | 2 | 2023 | 4340 | 0.040 |
Why?
| | Blotting, Western | 2 | 2014 | 1177 | 0.040 |
Why?
| | Cues | 1 | 2023 | 326 | 0.040 |
Why?
| | Rubella | 1 | 2020 | 23 | 0.040 |
Why?
| | Tissue Fixation | 1 | 2020 | 35 | 0.040 |
Why?
| | Psychotropic Drugs | 1 | 2021 | 75 | 0.040 |
Why?
| | Diatoms | 1 | 2020 | 13 | 0.040 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2020 | 35 | 0.040 |
Why?
| | Apoptosis | 2 | 2019 | 2439 | 0.040 |
Why?
| | Paraffin Embedding | 1 | 2020 | 33 | 0.040 |
Why?
| | Pathology, Molecular | 1 | 2020 | 28 | 0.040 |
Why?
| | Blood Chemical Analysis | 1 | 2020 | 109 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2021 | 109 | 0.040 |
Why?
| | Formaldehyde | 1 | 2020 | 66 | 0.040 |
Why?
| | Transaminases | 1 | 2020 | 22 | 0.040 |
Why?
| | Phosphorylation | 2 | 2014 | 1724 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 157 | 0.040 |
Why?
| | Fertility | 1 | 2021 | 174 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2020 | 170 | 0.040 |
Why?
| | Junin virus | 1 | 2019 | 1 | 0.040 |
Why?
| | Codon | 1 | 2020 | 92 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 2019 | 38 | 0.040 |
Why?
| | Reptiles | 1 | 2019 | 4 | 0.040 |
Why?
| | HeLa Cells | 2 | 2012 | 636 | 0.040 |
Why?
| | Electron Transport Complex III | 1 | 2019 | 18 | 0.040 |
Why?
| | DNA, Bacterial | 1 | 2021 | 319 | 0.040 |
Why?
| | Haplotypes | 1 | 2021 | 506 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 2019 | 6 | 0.040 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2020 | 175 | 0.040 |
Why?
| | Antigens, Viral | 1 | 2020 | 186 | 0.040 |
Why?
| | Convalescence | 1 | 2019 | 19 | 0.040 |
Why?
| | Erythrocebus | 1 | 2019 | 1 | 0.040 |
Why?
| | Postoperative Period | 1 | 2020 | 355 | 0.040 |
Why?
| | Asia, Western | 1 | 2019 | 5 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2021 | 237 | 0.040 |
Why?
| | Endothelium, Vascular | 2 | 2019 | 952 | 0.040 |
Why?
| | U937 Cells | 1 | 2018 | 28 | 0.040 |
Why?
| | Viral Matrix Proteins | 1 | 2018 | 28 | 0.040 |
Why?
| | Analgesics | 1 | 2021 | 230 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2021 | 615 | 0.040 |
Why?
| | Fishes | 1 | 2019 | 111 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2006 | 1468 | 0.030 |
Why?
| | Cyclin D1 | 1 | 2018 | 64 | 0.030 |
Why?
| | Sertoli Cells | 1 | 2018 | 26 | 0.030 |
Why?
| | Transfection | 2 | 2011 | 916 | 0.030 |
Why?
| | Metagenome | 1 | 2019 | 127 | 0.030 |
Why?
| | Anesthetics, Dissociative | 1 | 2018 | 49 | 0.030 |
Why?
| | Acute Disease | 1 | 2021 | 1038 | 0.030 |
Why?
| | Purines | 1 | 2019 | 188 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 140 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2019 | 218 | 0.030 |
Why?
| | Endocrine Glands | 1 | 2018 | 14 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 563 | 0.030 |
Why?
| | Ethanol | 1 | 2023 | 630 | 0.030 |
Why?
| | Peripheral Nervous System | 1 | 2018 | 20 | 0.030 |
Why?
| | Sf9 Cells | 1 | 2017 | 11 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2026 | 3017 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 237 | 0.030 |
Why?
| | Tight Junctions | 1 | 2018 | 87 | 0.030 |
Why?
| | Spodoptera | 1 | 2017 | 39 | 0.030 |
Why?
| | Genitalia | 1 | 2018 | 32 | 0.030 |
Why?
| | Transcription Factors | 1 | 2006 | 1730 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11913 | 0.030 |
Why?
| | RNA Editing | 1 | 2017 | 26 | 0.030 |
Why?
| | Machine Learning | 1 | 2023 | 594 | 0.030 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1432 | 0.030 |
Why?
| | Epididymis | 1 | 2017 | 14 | 0.030 |
Why?
| | Exosomes | 1 | 2018 | 104 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2018 | 239 | 0.030 |
Why?
| | Autopsy | 1 | 2017 | 96 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2018 | 4118 | 0.030 |
Why?
| | Poultry | 1 | 2017 | 9 | 0.030 |
Why?
| | Sample Size | 1 | 2017 | 124 | 0.030 |
Why?
| | Databases, Factual | 1 | 2023 | 1493 | 0.030 |
Why?
| | Sex Ratio | 1 | 2017 | 17 | 0.030 |
Why?
| | Drug Combinations | 1 | 2018 | 400 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 179 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1888 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1053 | 0.030 |
Why?
| | Blotting, Northern | 1 | 2017 | 197 | 0.030 |
Why?
| | Neurons | 1 | 2026 | 1668 | 0.030 |
Why?
| | Air Movements | 1 | 2016 | 9 | 0.030 |
Why?
| | HSC70 Heat-Shock Proteins | 1 | 2016 | 4 | 0.030 |
Why?
| | Medical Waste Disposal | 1 | 2016 | 4 | 0.030 |
Why?
| | Laboratory Personnel | 1 | 2016 | 4 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 370 | 0.030 |
Why?
| | Climate | 1 | 2017 | 79 | 0.030 |
Why?
| | Environment, Controlled | 1 | 2016 | 22 | 0.030 |
Why?
| | Vitreous Body | 1 | 2017 | 118 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 2016 | 36 | 0.030 |
Why?
| | Microscopy | 1 | 2018 | 147 | 0.030 |
Why?
| | Nucleotide Motifs | 1 | 2016 | 36 | 0.030 |
Why?
| | Animal Welfare | 1 | 2016 | 19 | 0.030 |
Why?
| | Geography | 1 | 2017 | 187 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 790 | 0.030 |
Why?
| | Nanopores | 1 | 2016 | 13 | 0.030 |
Why?
| | Diamines | 1 | 2016 | 5 | 0.030 |
Why?
| | Polysaccharides | 1 | 2016 | 88 | 0.030 |
Why?
| | Lentivirus | 1 | 2016 | 61 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 916 | 0.030 |
Why?
| | trans-Golgi Network | 1 | 2016 | 15 | 0.030 |
Why?
| | Antibody-Dependent Enhancement | 1 | 2016 | 2 | 0.030 |
Why?
| | General Practice | 1 | 2016 | 32 | 0.030 |
Why?
| | Epidemics | 1 | 2017 | 97 | 0.030 |
Why?
| | Tidal Volume | 1 | 2016 | 108 | 0.030 |
Why?
| | Genetic Vectors | 1 | 2017 | 327 | 0.030 |
Why?
| | Benzothiazoles | 1 | 2016 | 39 | 0.030 |
Why?
| | Apathy | 1 | 2016 | 8 | 0.030 |
Why?
| | Travel | 1 | 2017 | 134 | 0.030 |
Why?
| | RNA, Satellite | 1 | 2015 | 1 | 0.030 |
Why?
| | Academies and Institutes | 1 | 2016 | 61 | 0.030 |
Why?
| | Serogroup | 1 | 2015 | 46 | 0.030 |
Why?
| | Coitus | 1 | 2015 | 24 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2016 | 129 | 0.030 |
Why?
| | Cortical Synchronization | 1 | 2015 | 12 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2022 | 931 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 876 | 0.030 |
Why?
| | Unsafe Sex | 1 | 2015 | 62 | 0.030 |
Why?
| | Medication Adherence | 1 | 2019 | 535 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 415 | 0.030 |
Why?
| | Organic Chemicals | 1 | 2016 | 113 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 993 | 0.030 |
Why?
| | Motivation | 1 | 2019 | 605 | 0.030 |
Why?
| | Topography, Medical | 1 | 2014 | 10 | 0.030 |
Why?
| | Quinolines | 1 | 2016 | 191 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 857 | 0.030 |
Why?
| | Heart Rate | 1 | 2018 | 846 | 0.030 |
Why?
| | Psychological Tests | 1 | 2015 | 127 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1292 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1463 | 0.030 |
Why?
| | Drug Resistance, Viral | 1 | 2015 | 127 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1242 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 174 | 0.030 |
Why?
| | Acari | 1 | 2013 | 2 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 6077 | 0.030 |
Why?
| | Photic Stimulation | 1 | 2015 | 265 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2014 | 129 | 0.020 |
Why?
| | Signal Transduction | 2 | 2019 | 5246 | 0.020 |
Why?
| | Actins | 1 | 2016 | 422 | 0.020 |
Why?
| | Hantaan virus | 1 | 2013 | 1 | 0.020 |
Why?
| | La Crosse virus | 1 | 2013 | 4 | 0.020 |
Why?
| | rab5 GTP-Binding Proteins | 1 | 2013 | 10 | 0.020 |
Why?
| | Regression Analysis | 1 | 2016 | 999 | 0.020 |
Why?
| | Adaptor Protein Complex 2 | 1 | 2013 | 11 | 0.020 |
Why?
| | Chronic Disease | 1 | 2019 | 1827 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2014 | 147 | 0.020 |
Why?
| | Diagnostic Tests, Routine | 1 | 2014 | 109 | 0.020 |
Why?
| | Cercopithecus | 1 | 2012 | 3 | 0.020 |
Why?
| | Mood Disorders | 1 | 2014 | 130 | 0.020 |
Why?
| | rab GTP-Binding Proteins | 1 | 2013 | 76 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 334 | 0.020 |
Why?
| | Vaccines, Virosome | 1 | 2012 | 1 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1361 | 0.020 |
Why?
| | Survival Analysis | 1 | 2015 | 1378 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2013 | 201 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2013 | 533 | 0.020 |
Why?
| | Genetic Markers | 1 | 2012 | 340 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 457 | 0.020 |
Why?
| | Social Behavior | 1 | 2014 | 279 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 117 | 0.020 |
Why?
| | Risk Factors | 1 | 2026 | 10921 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4351 | 0.020 |
Why?
| | Middle East | 1 | 2011 | 18 | 0.020 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 25 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1998 | 0.020 |
Why?
| | Small Molecule Libraries | 1 | 2012 | 113 | 0.020 |
Why?
| | Cytokines | 1 | 2019 | 2081 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 334 | 0.020 |
Why?
| | Bone Marrow Stromal Antigen 2 | 1 | 2010 | 11 | 0.020 |
Why?
| | Research Design | 1 | 2017 | 1143 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1408 | 0.020 |
Why?
| | GPI-Linked Proteins | 1 | 2010 | 81 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 612 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 559 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2010 | 335 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 6034 | 0.020 |
Why?
| | Iron Metabolism Disorders | 1 | 2008 | 6 | 0.020 |
Why?
| | Structural Homology, Protein | 1 | 2008 | 21 | 0.020 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2008 | 16 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 106 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3712 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2791 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2919 | 0.020 |
Why?
| | Tyrosine | 1 | 2008 | 217 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1163 | 0.020 |
Why?
| | Emigration and Immigration | 1 | 2007 | 67 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 161 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 558 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2921 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2009 | 729 | 0.010 |
Why?
| | Viverridae | 1 | 2005 | 1 | 0.010 |
Why?
| | Antibodies | 1 | 2007 | 400 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1792 | 0.010 |
Why?
| | Iron | 1 | 2007 | 359 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2005 | 235 | 0.010 |
Why?
| | Incidence | 1 | 2011 | 2936 | 0.010 |
Why?
| | Asia, Central | 1 | 2003 | 1 | 0.010 |
Why?
|
|
Kuhn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|